why choose us

First received: October 27, 2022

Clinical Trial: Assessment of the Malaria Vaccine Candidate SumayaVac-1 in Healthy Adults Aged 18-45 Years Living in a Malaria Endemic Country

Study Status: COMPLETED

Recruit Status: COMPLETED

Condition: Malaria

Study Type: INTERVENTIONAL


Official Title: A Randomised, Controlled, Double-blind, Parallel Group, Single Center Phase Ib Trial to Assess Safety, Reactogenicity and Immunogenicity of a Candidate Dual-stage Malaria Vaccine, SumayaVac-1 (MSP-1 W

Brief Summary: Malaria remains a major infectious disease causing a heavy burden of mortality and morbidity in populations living in tropical and subtropical regions.Large, international research efforts have been invested into the development of anti-malaria vaccination strategies, however, currently there is only one malaria vaccine approved for use in the pediatric population, which provides a moderate and short-lived protection.Therefore, there is a need to develop a malaria vaccine that will be essential to further…

Read more